Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-26-045553
Filing Date
2026-04-20
Accepted
2026-04-20 17:23:57
Documents
4
Period of Report
2026-04-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2612245d1_pre14a.htm PRE 14A 100576
2 GRAPHIC tm2612245d1_per14aimg001.jpg GRAPHIC 15536
3 GRAPHIC tm2612245d1_pre14aimg002.jpg GRAPHIC 127493
4 GRAPHIC tm2612245d1_pre14aimg003.jpg GRAPHIC 99277
  Complete submission text file 0001104659-26-045553.txt   428418
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-12584 | Film No.: 26876105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)